Advertisement
  • Medicare Coverage for Next-Generation Sequencing Tests

    Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.

    by Ashley P. Taylor

  • On Cancer and Identity

    The first time Liza Bernstein was diagnosed with cancer, she wouldn't allow it to be part of her identity. After her third cancer diagnosis, she became an advocate for other patients.

    by Liza Bernstein

  • Opioid Overdoses in Cancer Patients and Survivors

    The number of cancer patients and survivors visiting emergency departments for opioid overdoses more than doubled between 2006 and 2015, but overdoses are still uncommon in this group.

    by Emma Yasinski

  • “Congrats! You Have the ‘Good’ Cancer”

    Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.

    by Carly Flumer

  • Policy Matters

    Keep Up Momentum for Medical Research Funding

    Advocating for federal funds for medical research pays off when the effort is constant and compelling.

    by Brandon L. Leonard, MA, and J. Tod Guidry, PhD

  • Get Involved

    Creative Therapy

    Various kinds of artistic expression can play a role in processing the emotional effects of cancer.

    by Bradley Jones

  • Secure Connections

    Patients find each other online and get support they say is unparalleled, but with openness comes concern about privacy.

    by Kate Yandell

  • Survivor Profile

    Handle With Care

    Brain cancer survivor Lanette Veres sends cards and packages to others with the disease. She believes no one should face cancer alone.

    by Lindsey Konkel

  • Forward Look

    Targeted Treatments for Tots

    New law mandates that cancer drugs get tested in kids in clinical trials.

    by Sharon Tregaskis

  • Forward Look

    Medicare to Cover CAR-T Cell Therapy

    High cost may still limit access.

    by Nancy Averett